Search
Now showing items 1-10 of 70
-
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards: draft
(2020-03)In a preliminary clinical study we observed that the combination of hydroxychloroquine and azithromycin was effective active against SARS-CoV-2 by shortening the duration of viral load in Covid-19 patients. It is of paramount ... -
In vitro testing of Hydroxychloroquine and Azithromycin on SARS-CoV-2 shows synergistic effect
(2020-03)Human coronaviruses SARS-CoV-2 appeared at the end of 2019 and led to a pandemic with high morbidity and mortality. As there are currently no effective drugs targeting this virus, drug repurposing represents a short-term ... -
Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up
(2020-03-15)[Abstract]. Objective: To investigate the characteristics and prognostic factors in the elderly patients with COVID-19. Methods: Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from ... -
Creating a Palliative Care Inpatient Response Plan for COVID19 – The UW Medicine Experience
(2020-03-24)[Abstract]. Introduction: The COVID-19 pandemic is stressing healthcare systems throughout the world. Significant numbers of patients are being admitted to the hospital with severe illness, often in the setting of advanced ... -
Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how
(2020-04-02)Plasma provided by COVID‐19 convalescent patients may provide therapeutic relief as the number CODID‐19 cases escalate steeply world‐wide. Prior findings in various viral respiratory diseases including SARS‐CoV related ... -
Pivotal Role of Convalescent Plasma in Managing Emerging Infectious Diseases
(2020-04-02)Infectious diseases remain one of the top 10 global health threats as announced by the World Health Organization. The emergence of new pathogens for which there is no effective treatment has redrawn the attention to the ... -
Clinical characteristics of Non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A Retrospective study
(2020-04-02)[Abstract]. Background & Aims: Coronavirus disease 2019 (COVID‐19) has raised world concern for global epidemic since December, 2019. Limited data are available for liver function in COVID‐19 patients. We aimed to investigate ... -
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
(2020-04-01)Motivation: Since December 2019, the newly identified coronavirus SARS-CoV-2 has caused a massive health crisis worldwide and resulted in over 70,000 COVID-19 infections so far. Clinical drugs targeting SARS-CoV-2 are ... -
Breastfeeding and Coronavirus Disease‐2019. Ad interim indications of the Italian Society of Neonatology endorsed by the Union of European Neonatal & Perinatal Societies
(2020-04-03)[Abstract]. The recent COVID‐19 pandemic has spread to Italy with heavy consequences on public health and economics. Besides the possible consequences of COVID‐19 infection on a pregnant woman and the fetus, a major concern ... -
Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis
(2020-04-03)[Abstract]. Background: Currently, the epidemic of Coronavirus Disease 2019 (COVID‐19) has begun to spread worldwide. We aim to explore reliable evidences for the diagnosis and treatment of the COVID‐19 by analyzing all ...